Bicycle Therapeutics (BCYC) Depreciation and Depletion (2018 - 2024)
Bicycle Therapeutics (BCYC) posted Depreciation and Depletion of $1.6 million for Q2 2024, down 5.88% on a QoQ basis from $1.7 million in Q1 2024, and little changed year-over-year from $1.6 million in Q3 2023.
Bicycle Therapeutics (BCYC) Depreciation and Depletion (2018 - 2024) Analysis & Trends
Bicycle Therapeutics' Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $1.6 million for Q2 2024.
- Quarterly Depreciation and Depletion changed 0.0% year-over-year to $1.6 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $6.6 million (up 10.0% YoY) and the FY2023 annual result came in at $6.5 million, up 75.68% from the prior year.
- Depreciation and Depletion was $1.6 million for Q2 2024 at Bicycle Therapeutics, down from $1.7 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $1.7 million in Q3 2023 and bottomed at $300000.0 in Q1 2020.
- A 5-year average of $900000.0 and a median of $500000.0 in 2020 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2020 — Depreciation and Depletion plunged 50.0% — and 2022, when it jumped 333.33%.
- Bicycle Therapeutics' Depreciation and Depletion stood at $400000.0 in 2020, then changed by 0.0% to $400000.0 in 2021, then jumped by 275.0% to $1.5 million in 2022, then grew by 6.67% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024.
- Business Quant data shows BCYC's Depreciation and Depletion at $1.6 million in Q2 2024, $1.7 million in Q1 2024, and $1.6 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 1.70 Mn |
| Sep 30, 2023 | 1.70 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | 1.30 Mn |
| Sep 30, 2022 | 1.30 Mn |
| Jun 30, 2022 | 600,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Mar 31, 2022 | 400,000.00 |